Clinical Trials for Carcinoma, Squamous Cell

Find clinical trials for carcinoma, squamous cell. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

NCT ID: NCT06912087

This clinical trial is investigating a new treatment approach for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, a type of cancer that has come back or spread a...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

NCT ID: NCT03370406

This clinical trial is exploring a new way to treat squamous cell carcinoma (SCC) on the lower legs by directly delivering medication to the tumor. Researchers are testing two methods: an injection...

Recruiting

Phase: PHASE1 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

NCT ID: NCT04564989

This clinical trial is studying a type of throat cancer known as HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). The main goal is to see if doctors can predict whether this cancer wil...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States, Chapel Hill, North Carolina, United States +1 more

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

NCT ID: NCT05955924

This clinical trial is studying whether a form of Vitamin B3 called nicotinamide can help prevent skin cancer in patients who have received organ transplants, such as kidney, liver, heart, or lung ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Toronto, Ontario, Canada, Vancouver, British Columbia, Canada +6 more

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

NCT ID: NCT06669572

This clinical trial is looking at a combination of two drugs, lenvatinib and pembrolizumab, to see if they can help patients with anal or rectal cancer that has worsened after standard treatments. ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

NCT ID: NCT04429542

This clinical trial is studying a new experimental drug called BCA101 to see how safe it is and how well it works on patients with certain types of advanced cancers that are driven by a protein cal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Providence, Rhode Island, United States, Heidelberg, Victoria, Australia +18 more

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT ID: NCT04099290

This clinical trial is studying a blood test called circulating tumor DNA (ctDNA) to learn more about head and neck squamous cell carcinoma, a type of cancer that affects the mouth, throat, and lar...

Recruiting

Type: observational Locations: Chapel Hill, North Carolina, United States

TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY

NCT ID: NCT04481256

This clinical trial is studying a new treatment option for patients with a type of esophageal cancer called squamous cell carcinoma. The researchers want to see if a drug called bintrafusp alfa, wh...

Recruiting

Phase: NA Type: interventional Locations: Amsterdam, , Netherlands

Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma

NCT ID: NCT06383728

This clinical trial is studying a new treatment approach for patients with a specific type of lung cancer called EGFR-mutated lung squamous cell carcinoma. The goal is to see if a targeted therapy,...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

NCT ID: NCT02290145

This clinical trial is studying a new treatment approach for patients with oral squamous cell carcinoma (a type of mouth cancer) who are at a specific stage of the disease (known as clinical N2). T...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

GDF15 Based TPF Induction Chemotherapy for OSCC Patients

NCT ID: NCT02285530

This clinical trial is looking at a new treatment approach for patients with a specific type of mouth cancer called squamous cell carcinoma. The researchers want to see how well a drug called GDF15...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

NCT ID: NCT05252078

This clinical trial is investigating the effects of two medications, Anlotinib Hydrochloride Capsules and TQB2450 Injection, in patients with esophageal squamous cell carcinoma (ESCC) who have rece...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanchang, Jiangxi, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions